We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Multiplex Assay Identifies Diarrheagenic Escherichia coli

By LabMedica International staff writers
Posted on 14 Aug 2014
A rapid, reliable and repeatable method is urgently needed for identifying diarrheagenic Escherichia coli (DEC) so as to provide the reference for responding to diarrheal disease outbreaks and the treatment of the diarrheal patients associated with DEC.

A multiplex real-time polymerase chain reaction (PCR) assay based multicolor-combinational probe coding (MCPC) for the identification of eight foodborne pathogens has been developed and applied to the rapid diagnosis of a foodborne disease outbreak successfully.

Molecular biologists at the Xiamen University (China) designed specific primers and modified molecular beacon probes of nine specific virulence genes, whose 5′ end were added with homo tail sequence. More...
They developed and optimized a two-tube modified molecular beacon based multiplex real-time PCR (rtPCR) assay for the identification of five Escherichia coli pathotypes.

A total of 102 bacterial strains, including 52 reference bacterial strains and 50 clinical strains, were isolated to confirm whether the target genes selected were specific. The detection limits of the assay were then tested. Lastly, the assay was applied to the detection of 11,860 clinical samples to evaluate the specificity and sensitivity of the developed assay compared with the conventional PCR. Multiplex rtPCR reactions were performed on the Bio-Rad CFX 96 Real-Time PCR System (Bio-Rad; Hercules, CA, USA).

The target genes were 100% specific as assessed on 102 bacterial strains since no cross-reactions were observed. The detection limits ranged from 88 colony forming units (CFU)/mL for Enterohemolysin E. coli (EHEC) to 880 CFU/mL Enteropathogenic E. coli (EPEC). Compared with the conventional PCR, the specificity and sensitivity of the multiplex rtPCR was 100% and over 99%, respectively. The coefficient of variation (CV) for each target gene ranged from 0.45% to 1.53%. Of the 171 positive clinical samples, 111 (64.9%) were identified as Enterotoxigenic E. coli (ETEC) and 38 (22.2%) as Enteropathogenic E. coli which were the dominating pathotypes of DEC strains.

The authors concluded that they had developed a rapid and effective two-tube multiplex rtPCR for the identification of all DEC pathotypes. This method took only 90 minutes and saved resources including biochemical reagents, disposable medical supplies and could be used in clinical and public health laboratories. The study was published on July 15, 2014, in the journal Annals of Clinical Microbiology and Antimicrobials.

Related Links:

Xiamen University
Bio-Rad



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.